Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New drugs could help fight antibiotic resistance
Image pills
Current antibiotics work by killing bacteria, or stopping it from growing.
AV drugs stop bacteria from harming the host

Scientists say a new type of drug could help fight antibiotic resistance, by stopping bacteria from harming the host.

Current antibiotics aim to kill bacteria, or stop them growing, but scientists from the University of Edinburgh say this dramatically alters how the bugs evolve and helps resistant strains to survive.

After conducting a five-year review of research in the field, scientists believe anti-virulence (AV) drugs could stop the growing resistance to antibiotics.

AV drugs work by stopping the harmful part of the bacteria from functioning - without directly harming or killing the bugs. In this way, the treat the infection without promoting drug resistance.

Experts warn that as antibiotic resistance grows, curable infections could become life-threatening if the bacteria responsible becomes immune to current treatments.

According to the team from Edinburgh, recent research suggests AV drugs could provide an effective and longer lasting alternative to existing treatments.

Findings indicate the new drugs could work well alone, or combined with existing drugs.

"Our findings reveal that there are opportunities to make real progress in the fight against antibiotic resistance," said researcher Richard Allen.

"Gaining a greater understanding of how virulence affects bacterial growth in the host should aid us in our efforts to develop effective AV drugs."

The study has been published in the journal Nature Reviews Microbiology.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com